Cabio Biotech (Wuhan) Co., Ltd. (SHSE: 688089)
Materials · Chemicals · CN
CN¥7.51
-2.72% today · -73.2% 1Y
Cabio Biotech (Wuhan) Co., Ltd. (SHSE: 688089) operates in the Chemicals industry within the Materials sector. The company is valued at $183.78M and employs 595 people.
Over the last twelve months the share price has lost 73.2%, trading between 6.91 and 31.13.
Tweenvest scores Cabio Biotech (Wuhan) Co., Ltd. across four factors: quality 85/100, value 59/100, growth 76/100. Its strongest factor is quality.
688089 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $183.78M
- Revenue (TTM)
- $46.22M
- P/E
- —
- EPS
- -0.39
- Dividend yield
- —
- Beta (5Y)
- 0.38
- 52-week high
- CN¥31.13
- 52-week low
- CN¥6.91
- Avg volume (3M)
- —
- Shares outstanding
- 164.51M
- Employees
- 595
- Next earnings
- —
About Cabio Biotech (Wuhan) Co., Ltd.
Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production and sale of polyunsaturated fatty acids and nutrition products. Its products include arachidonic acids (ARA), docosahexaenoic acids (DHA), natural beta-carotene products, infant formula food, functional healthcare food and dietary supplements. The company was founded on September 22, 2004 and is headquartered in Wuhan, China.
- ISIN
- CNE100005X31
- Founded
- 1999
- Listed since
- Dec 19, 2019
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Chemicals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Linde plcNasdaqGS: LIN | $224.59B | $490.02 | +0.58% |
| L'Air Liquide S.A.ENXTPA: AI | $124.62B | €168.72 | +0.56% |
| The Sherwin-Williams CompanyNYSE: SHW | $84.57B | $347.81 | -0.75% |
| Ecolab Inc.NYSE: ECL | $81.17B | $290.52 | +0.34% |
| Shin-Etsu Chemical Co., Ltd.TSE: 4063 | $70.11B | ¥6,005.00 | -0.76% |
| Air Products and Chemicals, Inc.NYSE: APD | $67.66B | $306.64 | +0.92% |
| Corteva, Inc.NYSE: CTVA | $55.41B | $83.02 | -0.04% |
| BASF SEXTRA: BAS | $51.92B | €51.78 | +0.19% |
Figures last refreshed Aug 18, 2026.